细胞代谢组学研究进展

李维薇; 杨燕; 汪受传; 谢彤; 单进军

细胞代谢组学研究进展

李维薇^1,2,
杨燕³,
汪受传¹,
谢彤^1,2,
单进军^1,2,

1.
江苏省儿童呼吸疾病中医药重点实验室，南京中医药大学中医儿科学研究所，江苏南京 210023;南京中医药大学医学代谢组学中心，江苏南京 210023
3.
首都医科大学附属北京儿童医院，北京 100045

计量
- 文章访问数: 1375
- HTML全文浏览量: 16
- PDF下载量: 2217
- 被引次数: 0
出版历程
- 收稿日期: 2017-01-05
- 修回日期: 2017-02-19
- 刊出日期: 2017-03-10

Research Progress of Cellular Metabolomics

LIWei-wei^1,2,
YANGYan³,
WANGShou-chuan¹,
XIETong^1,2,
SHANJin-jun^{1,2
,}

1.
Jiangsu Key Laboratory of Pediatric Respiratory Disease, Institute of Pediatrics, Nanjing University of Chinese Medicine, Nanjing, 210023, China
3.
Medical Metabolomics Center, Nanjing University of Chinese Medicine, Nanjing, 210023, China

摘要

摘要: 代谢组学可以定性或定量分析生物体内源性代谢物及其对内外因素的应答规律。细胞代谢组学是代谢组学近年来的新兴领域，广泛运用于疾病机制研究、药理学、毒理学研究等并取得了一系列成果。简要综述细胞代谢组学近年来方法学的优化及在中西医领域的研究进展。
- 细胞代谢组学 /
- 方法学 /
- 病原体 /
- 肿瘤 /
- 中医药
Abstract: Metabolomics aims at qualitative and quantitative analysis of the endogenous metabolites and organism response law of inside and outside factors. Cellular metabolomics is an emerging field of metabolomics in recent years. It's widely used in the study of disease mechanism， pharmacology， toxicology and has obtained a series of achievements. This review outlines the progress of methodology in cellular metabolomics and its application in the field of medicine.
- cellular metabolomics /
- methodology /
- pathogens /
- tumor /
- Chinese medicine

HTML全文

参考文献(57)

[1]	TANG H， WANG Y. Metabonomics: a revolution in progress[J]. Progr Biochem Biophys， 2006， 33(5):401-417.
[2]	NICHOLSON JK， LINDON JC， HOLMES E. Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J]. Xenobiotica， 1999， 29(11):1181.
[3]	ROCHFORT S. Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research.[J]. J Nat Prod， 2005， 68(12):1813
[4]	TANG H， WANG Y. Metabonomics: a revolution in progress[J]. Progr Biochem Biophy， 2006， 33(5):401-417.
[5]	PATTI GJ， YANES O， SIUZDAK G. Metabolomics: the apogee of the omic triology[J]. Nat Rev Mol Cell Biol， 2011， 13(4):263.
[6]	WANG M， LAMERS RJ， KORTHOUT HA， et al. Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology.[J]. Phytother Res， 2005， 19(3):173-182.
[7]	WU T， YANG M， WEI H F， et al. Application of metabolomics in traditional Chinese medicine differentiation of deficiency and excess syndromes in patients with diabetes mellitus[J]. Evid-bas Compl Alternat Med，2012， 2012(3):968083.
[8]	DU L N， XIE T， XU J Y， et al. A metabolomics approach to studying the effects of Jinxin oral liquid on RSV-infected mice using UPLC/LTQ-Orbitrap mass spectrometry.[J]. J Ethnopharmacol， 2015， 174:25-36.
[9]	HU C， XU G. Metabolomics and traditional Chinese medicine[J]. Trac Trend Analyt Chem， 2014， 61(1):207-214.
[10]	VEYRAT-DUREBEX C， CORCIA P， PIVER E， et al. Disruption of TCA cycle and glutamate metabolism identified by metabolomics in an in vitro model of Amyotrophic Lateral Sclerosis[J]. Mol Neurobiol， 2015， 53(10):1-15.
[11]	LE A， LANE AN， HAMAKER M， et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells[J]. Cell Metab， 2012， 15(1):110-121.
[12]	KADDURAHDAOUK R， KRISTAL BS， WEINSHILBOUM RM. Metabolomics: a global biochemical approach to drug response and disease.[J]. Ann Rev Pharm， 2008， 48(48):653.
[13]	WEST PR， WEIR AM， SMITH AM， et al. Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics[J]. Toxicol Appl Pharm， 2010， 247(1):18-27.
[14]	ALLEN J， DAVEY HM， BROADHURST D， et al. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting.[J]. Nat Biotechnol， 2003， 21(6):692.
[15]	BALCKE GU， KOLLE SN， KAMP H， et al. Linking energy metabolism to dysfunctions in mitochondrial respiration: a metabolomics in vitro approach.[J]. Toxicol Lett， 2011， 203(3):200-209.
[16]	CUPERLOVICCULF M， BARNETT DA， CULF AS， et al. Cell culture metabolomics: applications and future directions.[J]. Drug Discov Today， 2010， 15(15/16):610-621.
[17]	CAJKA T， FIEHN O. Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry[J]. Trac Trend Anal Chem， 2014， 61:192-206.
[18]	FESSENDEN M. Metabolomics: Small molecules， single cells[J]. Nature， 2016， 540(7631):153-155.
[19]	EWING A. Mass spectrometry imaging of lipids and metabolites: from fruit fly brains to single nanometer vesicles[J]. New Biotechnol， 2016， 33:S21-S21.
[20]	DUNN WB， ELLIS DI. Metabolomics: Current analytical platforms and methodologies[J]. Trac Trend Anal Chem， 2005， 24(4):285-294.
[21]	ALDER L， GREULICH K， KEMPE G， et al. Residue analysis of 500 high priority pesticides: better by GC-MS or LC-MS/MS?[J]. Mass Spectrom Rev， 2006， 25(6):838-865.
[22]	KRONTHALER J， GSTRAUNTHALER G， HEEL C. Optimizing high-throughput metabolomic biomarker screening: a study of quenching solutions to freeze intracellular metabolism in CHO cells.[J]. Omics J Integr Biol， 2012， 16(3):90.
[23]	MADJI HB， BLASCO H， NADALDESBARATS L， et al. Analytical methodology for metabolomics study of adherent mammalian cells using NMR， GC-MS and LC-HRMS.[J]. Anal Bioanal Chem， 2015， 407(29):8861-8872.
[24]	ZHAO Q， LIU HQ， LU Y， et al. Comparison of Quenching and Extraction Methods for Metabolome Analysis of Vibrio Parahaemolyticus[J]. Chin J Anal Chem， 2012， 39(11):1689-1694.
[25]	LORENZ MA， BURANT CF， KENNEDY RT. Reducing Time and Increasing Sensitivity in Sample Preparation for Adherent Mammalian Cell Metabolomics[J]. Anal Chem， 2011， 83(9):3406.
[26]	BOLTEN CJ， KIEFER P， LETISSE F， et al. Sampling for metabolome analysis of microorganisms.[J]. Anal Chem， 2007， 79(10):3843-3849.
[27]	SHEIKH KD， KHANNA S， BYERS SW， et al. Small molecule metabolite extraction strategy for improving LC/MS detection of cancer cell metabolome.[J]. J Biomol Techn Jbt， 2011， 22(22):1-4.
[28]	SELLICK CA， KNIGHT D， CROXFORD AS， et al. Evaluation of extraction processes for intracellular metabolite profiling of mammalian cells: matching extraction approaches to cell type and metabolite targets[J]. Metabolomics， 2010， 6(3):427-438.
[29]	DIETMAIR S， TIMMINS NE， GRAY PP， et al. Towards quantitative metabolomics of mammalian cells: development of a metabolite extraction protocol.[J]. Anal Biochem， 2010， 404(2):155-164.
[30]	LEON Z， GARCIA-CANAVERAS JC， DONATO MT， et al. Mammalian cell metabolomics: Experimental design and sample preparation[J]. Electrophoresis， 2013， 34(19):2762–2775.
[31]	CAJKA T， FIEHN O. Toward merging untargeted and targeted methods in mass spectrometry-based metabolomics and lipidomics[J]. Anal Chem， 2015， 88(1).
[32]	MUNGER J. Dynamics of the cellular metabolome during human cytomegalovirus infection.[J]. Plos Pathogens， 2006， 2(12):e132.
[33]	SILVA L P， LORENZI PL， PURWAHA P， et al. Measurement of DNA concentration as a normalization strategy for metabolomic data from adherent cell lines[J]. Anal Chem， 2013， 85(20):9536-9542.
[34]	MUSCHET C， MOLLER G， PREHN C， et al. Removing the bottlenecks of cell culture metabolomics: fast normalization procedure， correlation of metabolites to cell number， and impact of the cell harvesting method[J]. Metabolomics， 2016， 12(10):151.
[35]	HUTSCHENREUTHER A， KIONTKE A， BIRKENMEIER G， et al. Comparison of extraction conditions and normalization approaches for cellular metabolomics of adherent growing cells with GC-MS[J]. Anal Meth， 2012， 4(7):1953-1963.
[36]	YEO DS， CHAN R， BROWN G， et al. Evidence that selective changes in the lipid composition of raft-membranes occur during respiratory syncytial virus infection.[J]. Virology， 2009， 386(1):168-182.
[37]	RITTER J B， WAHL A S， FREUND S， et al. Metabolic effects of influenza virus infection in cultured animal cells: Intra- and extracellular metabolite profiling[J]. BMC Syst Biol， 2010， 4(1):61.
[38]	LIN S， LIU N， YANG Z， et al. GC/MS-based metabolomics reveals fatty acid biosynthesis and cholesterol metabolism in cell lines infected with influenza A virus[J]. Talanta， 2010， 83(1):262-268.
[39]	WOODS PS， DOOLITTLE LM， ROSAS LE， et al. Lethal H₁N₁ influenza a virus infection alters the murine alveolar type Ⅱ cell surfactant lipidome[J]. Am J Physiol Lung Cell Mol Physiol， 2016:00339.
[40]	BIRUNGI G， CHEN SM， LOY BP， et al. Metabolomics approach for investigation of effects of dengue virus infection using the EA.hy926 cell line[J]. J Proteom Res， 2010， 9(12):6523-34.
[41]	YU T， WANG Y， ZHANG H， et al. Metabolomics reveals mycoplasma contamination interferes with the metabolism of PANC-1 cells.[J]. Anal Bioanal Chem， 2016， 408(16):4267-4273.
[42]	MEADOWS AL， KONG B， BERDICHEVSKY M， et al. Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells.[J]. Biotechnol Progr， 2008， 24(2):334.
[43]	WILLMANN L， SCHLIMPERT M， HIRSCHFELD M， et al. Alterations of the exo- and endometabolite profiles in breast cancer cell lines: A mass spectrometry-based metabolomics approach[J]. Anal Chim Acta， 2016， 925:34-42.
[44]	HALAMA A， RIESEN N， MOLLER G， et al. Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine.[J]. J Int Med， 2013， 274(5):425-439.
[45]	D'ALESSANDRO A， ZOLLA L. Metabolomics and cancer drug discovery: let the cells do the talking.[J]. Drug Discovery Today， 2012， 17(1–2):3-9.
[46]	DAN G， WANG Y， XIE W， et al. Metabolomics study on the antitumor effect of marine natural compound flexibilide in HCT-116 colon cancer cell line[J]. J Chromatogr B Anal Technol Biomed Life Sci， 2016， 1014:17.
[47]	BEI C， LI M， ZHA W， et al. Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells[J]. Metabolomics， 2013， 9(5):960-973.
[48]	LIU X， ZHANG CC， LIU Z， et al. LC-based targeted metabolomics analysis of nucleotides and identification of biomarkers associated with chemotherapeutic drugs in cultured cell models.[J]. Anti-cancer drug， 2014， 25(6):690.
[49]	TIZIANI S， LODI A， KHANIM FL， et al. Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines.[J]. Plos One， 2009， 4(1):e4251.
[50]	CHANG WT， THISSEN U， EHLERT KA， et al. Effects of growth conditions and processing on Rehmannia glutinosa using fingerprint strategy.[J]. Plant Med， 2006， 72(5):458-467.
[51]	ZHANG HY， HU CX， LIU CP， et al. Screening and analysis of bioactive compounds in traditional Chinese medicines using cell extract and gas chromatography–mass spectrometry[J]. J Pharm Biomed Anal， 2007， 43(1):151.
[52]	LI YH， WANG PX， XIAO W， et al. Screening and analyzing the potential bioactive components from reduning injection， using macrophage cell extraction and ultra-high performance liquid chromatography coupled with mass spectrometry[J]. Am J Chin Med， 2013， 41(1):221.
[53]	SHI J， ZHOU J， MA H， et al. An in vitro metabolomics approach to identify hepatotoxicity biomarkers in human L02 liver cells treated with pekinenal， a natural compound.[J]. Anal Bioanal Chem， 2016， 408(5):1413-1424.
[54]	LIU X， LIU Y， CHENG M， et al. Acute nephrotoxicity of aristolochic acid in vitro: metabolomics study for intracellular metabolic time-course changes.[J]. Biomarkers， 2016， 21(3):233-242.
[55]	XIE HH， XIE T， XU JY， et al. Metabolomics Study of Aconitine and Benzoylaconine Induced Reproductive Toxicity in BeWo Cell[J]. Chin J Anal Chem， 2015， 43(12):1808-1813.
[56]	XIE T， ZHOU X， WANG S， et al. Development and application of a comprehensive lipidomic analysis to investigate Tripterygium wilfordii-induced liver injury.[J]. Anal Bioanal Chem， 2016， 408(16):1-15.
[57]	XIE HH， XU JY， XIE T， et al. Effects of Pinellia ternata (Thunb.) Berit. on the metabolomic profiles of placenta and amniotic fluid in pregnant rats.[J]. J Ethnopharm， 2016， 183:38-45.